Ubs Group Ag Miromatrix Medical Inc. Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.92 - $2.03 $4,547 - $10,034	-4,943 Reduced 70.82%	2,037 $3,000
Q1 2023 May 12, 2023	BUY	$1.45 - $3.49 $10,121 - $24,360	6,980 New	6,980 $11,000
Q3 2022 Nov 10, 2022	BUY	$2.27 - $4.86 $4,928 - $10,551	2,171 Added 121.08%	3,964 $17,000
Q2 2022 Aug 10, 2022	SELL	$3.36 - $4.32 $1,552 - $1,995	-462 Reduced 20.49%	1,793 $7,000
Q1 2022 May 16, 2022	BUY	$2.03 - $4.73 $3,863 - $9,001	1,903 Added 540.63%	2,255 $9,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $9.4 $1,010 - $2,133	227 Added 181.6%	352 $2,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.75 $825 - $1,593	125 New	125 $1,000

Ticker MIRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,899,200
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.